XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stag⦠read more
Healthcare
Biotechnology
2 years
USD
Exclusive to Premium users
$25.45
Price+0.32%
$0.08
$307.632m
Small
25.4x
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$36.537m
-
1y CAGR-
3y CAGR-
5y CAGR-$2.859m
-
1y CAGR-
3y CAGR-
5y CAGR$12.10
-
1y CAGR-
3y CAGR-
5y CAGR$84.629m
$212.750m
Assets$128.121m
Liabilities$114.452m
Debt53.8%
-6.8x
Debt to EBITDA-$6.686m
-
1y CAGR-
3y CAGR-
5y CAGR